Myopia typically starts and progresses during childhood, but onset and progression can
occur during adulthood. The goals of this review are to summarize published data on …

A range of optical interventions have been developed to slow the progression of myopia.
This review summarizes key studies and their outcomes. Peer-reviewed, randomized …

Importance The global prevalence of myopia is predicted to approach 50% by 2050,
increasing the risk of visual impairment later in life. No pharmacologic therapy is approved …

Myopia is a dynamic and rapidly moving field, with ongoing research providing a better
understanding of the etiology leading to novel myopia control strategies. In 2019, the …

Importance Controlling myopia progression is of interest worldwide. Low-dose atropine eye
drops have slowed progression in children in East Asia. Objective To compare atropine …

Importance Myopia is a global concern, but effective prevention measures remain limited.
Premyopia is a refractive state in which children are at higher risk of myopia, meriting …

Purpose: Surveys in 2015 and 2019 identified a high level of eye care practitioner
concern/activity about myopia, but the majority still prescribed single vision interventions to …

The range of available myopia control modalities is increasing rapidly. 1 Likewise, the
number of studies assessing these various approaches is increasing exponentially. 2 …

Purpose Spectacle lenses containing multiple small peripheral elements have been
developed for myopia control in children. It is important that their effect on vision be …

In the field of myopia control, effective optical or pharmaceutical therapies are now available
to patients in many markets. This creates challenges for the conduct of placebo‐controlled …